Connexion
E-mail
Mot de passe
Retenir
Mot de passe oublié ?
Devenir membre gratuitement
Inscription
Inscription
Devenir membre
Inscription gratuite
Devenir client
Découvrez nos services
Paramètres
Paramètres
Cotations dynamiques 

Accueil Zonebourse  >  Actions  >  Nasdaq  >  Dendreon Corporation    

DENDREON CORPORATION

Mes dernières consult.
Top consultations
21
SynthèseGraphiquesActualitésAgendaSociétéFinancesFondsCommunauté 
Métier
Discovers, develops and commercializes novel products for the treatment of cancer

Dendreon Corp. is a biotechnology company, which focuses on discovery, development and commercialization of novel therapeutics that improves cancer treatment options for patients.

The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types.

It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers.

Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA.
Dirigeants
Nom AgeDepuisTitre
Craig R. Jalbert542015President, Secretary, Treasurer & Director
William Monteith572009Executive Vice President-Technical Operations
Andrew S. Sandler, MD502014Chief Medical Officer & Executive Vice President
April Falcone--Head-Corporate Communications
Silvio Pacheco, MBA--Chief Customer Officer
Karen Brophy522012Vice President & Head-Human Resources
Actions
Vote NombreFlottantAutocontrôleFlottant Total
Action A 1 158 716 893 153 327 147 96.6% 0 0.0% 96.6%
Secteur
Santé
Recherche pharmaceutique et médicale
 Recherche biotechnologique et médicale
  Recherche biotechnologique et médicale
   Recherche biotechnologique et médicale - NCA
Publicité
Secteur Recherche biotechnologique et médicale - NCA
Var. 1janvCapitalisation (M$)
DENDREON CORPORATION-55.48%0
INCYTE CORPORATION-17.95%16 728
CELLTRION, INC.--.--%11 664
LONZA GROUP AG13.18%10 059
QUINTILES TRANSNATIONA..15.66%9 453
SEATTLE GENETICS, INC.24.40%7 845
ALKERMES PLC-37.54%7 514
ALNYLAM PHARMACEUTICAL..-19.73%6 478
QIAGEN NV-3.58%6 391
UNITED THERAPEUTICS CO..-18.77%5 530
IONIS PHARMACEUTICALS ..-43.29%4 247
ICON PLC-1.57%4 242
ACADIA PHARMACEUTICALS..-1.88%4 189
BIO-TECHNE CORP20.38%4 041
CHARLES RIVER LABORATO..2.95%3 914
PAREXEL INTERNATIONAL ..2.97%3 730
PRA HEALTH SCIENCES IN..23.48%3 406
GALAPAGOS12.37%3 306
INTREXON CORP-9.09%3 243
BB BIOTECH AG-12.49%2 941
NEKTAR THERAPEUTICS11.28%2 564
Secteur Recherche biotechnologique et médicale - NCA
Dendreon Corporation : Connexions
CompuCyte Corp.
Seaside Therapeutics, Inc.
SIONEX Corp.
Coordonnées société
Dendreon Corp.
1301 2nd Avenue
Suite 3200
Seattle, WA 98101

Phone : +1.206.256.4545
Fax : +1.206.256.0571
Web : www.dendreon.com
© 2016 People , Fundamentals and Ownership